In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones

被引：9

作者：

Schmitz, FJ

Boos, M

Mayer, S

Köhrer, K

Scheuring, S

Fluit, AC

机构：

[1] Univ Hosp Dusseldorf, Inst Med Microbiol & Virol, D-40225 Dusseldorf, Germany

[2] Univ Med Ctr Utrecht, Eijkman Winkler Inst Med Microbiol, Utrecht, Netherlands

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002年 / 46卷 / 03期

关键词：

D O I：

10.1128/AAC.46.3.934-935.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：934 / 935

页数：2

共 8 条

[1] In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus
Boos, M
Mayer, S
Fischer, A
Köhrer, K
Scheuring, S
Heisig, P
Verhoef, J
Fluit, AC
Schmitz, FJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 938 - 942
[2] Antipneumococcal activities of gemifloxacin compared to those of nine other agents
Davies, TA
Kelly, LM
Pankuch, GA
Credito, KL
Jacobs, MR
Appelbaum, PC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 304 - 310
[3] Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756
Fung-Tomc, JC
Minassian, B
Kolek, B
Huczko, E
Aleksunes, L
Stickle, T
Washo, T
Gradelski, E
Valera, L
Bonner, DP
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3351 - 3356
[4] Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season
Jones, ME
Sahm, DF
Martin, N
Scheuring, S
Heisig, P
Thornsberry, C
Köhrer, K
Schmitz, FJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 462 - 466
[5] National Committee for Clinical Laboratory Studies, 1998, PERF STAND ANT SUSC
[6] Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC
Schmitz, FJ
Jones, ME
Hofmann, B
Hansen, B
Scheuring, S
Lückefahr, M
Fluit, A
Verhoef, J
Hadding, U
Heinz, HP
Köhrer, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1249 - 1252
[7] In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone
Takahata, M
Mitsuyama, J
Yamashiro, Y
Yonezawa, M
Araki, H
Todo, Y
Minami, S
Watanabe, Y
Narita, H
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1077 - 1084
[8] Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes:: Identification of gyrA and parC and specification of point mutations associated with resistance
Yan, SS
Fox, ML
Holland, SM
Stock, F
Gill, VJ
Fedorko, DP
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 3196 - 3198

← 1 →